Immunotherapy and Beyond in Metastatic NSCLC: Where Are We Now and What’s Next?

Review the latest clinical data on novel approaches for chemoimmunotherapy advanced/metastatic NSCLC with downloadable slides and an interactive webcast from a live, expert-led roundtable webinar.

Share

Program Content

Activities

Chemoimmunotherapy in NSCLC
Rationale for Chemoimmunotherapy in Metastatic NSCLC and Latest Clinical Trial Data
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

Managing AEs With Chemo-IO in NSCLC
Management of AEs With Chemoimmunotherapy in NSCLC and Promoting Diversity in Clinical Trials
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

Activities

Metastatic NSCLC Immunotherapy FAQs
Immunotherapy and Beyond in Metastatic NSCLC: Expert Answers to Your Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2024

Activities

Immunotherapy in Metastatic NSCLC
Immunotherapy and Beyond in Metastatic NSCLC: Where Are We Now and What’s Next?
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2023

Expires: December 11, 2024

Faculty

cover img faculity

Christine M. Bestvina, MD

Assistant Professor
Section of Hematology/Oncology
Division of Medicine
University of Chicago Medicine
Chicago, Illinois

cover img faculity

Elaine Shum, MD

Assistant Professor
NYU Grossman School of Medicine
NYU Perlmutter Cancer Center
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca